1. HBW Insight
  2. >>Ingredients & Safety

Sabinsa’s Curcumin Complex Reduces Inflammation In Traumatic Brain Injury Patients

 
• By Eileen Francis

Iranian researchers found using 500 mg curcumin complex daily for seven days reduced levels of leptin, which can promote inflammatory response, in patients with traumatic brain injury. In study published in Phytotherapy Research, 28 subjects had an overall 47.1% reduction in leptin.

Sainsa Headquarters

Sabinsa Corp.’s Curcumin C3 Complex could offer a major inflammatory-reduction benefit to traumatic brain injury patients, according to results of a study conducted by researchers from medical schools in Iran.

Among a panel of 62 patients in the double-blind, placebo-controlled and randomized study, daily use of a supplement with 500 mg C3 Complex and 5 mg of Sabinsa’s bioavailability enhancer...

Calling Out Exaggerated Amla Claims In Vitamin C

Sabinsa says competitors are attempting to cash in on growing demand for vitamin C by inaccurately claiming to offer high concentrations of the nutrient derived from amla extract.

...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

Review Suggests Advantage Of Bayer’s Iberogast Advance For Digestive Disorders

 
• By David Ridley

Bayer's Iberogast Advance's combination of six herbal ingredients may produce a synergistic effect that acts on multiple underlying issues contributing to digestive disorders like functional dyspepsia (FD) and irritable bowel syndrome (IBS), a recently published study suggests.

Allergy Ingredient Itch Warning, ACNU Final Rule Scratch Extent Of FDA Authority For Label Changes

 
• By Malcolm Spicer

Effective date for ACNU OTC switch final rule and finding of severe itching from long-term use of common allergy ingredients are bookends for limits of FDA’s authority for product label changes.

‘We Must Have The Truth’ – Calls For UWWTD Review Intensify As Evidence Looks ‘Shaky’

 
• By David Ridley

The evidence underpinning the “polluter pays” principle of the revised Urban Wastewater Treatment Directive - which calls on Europe's pharmaceutical industry to cough up at least 80% of the cost of updating wastewater treatment facilities - is looking increasingly shaky, according to a new report.

Supplementation Unlikely To Help With Hereditary Hair Loss, Says German Agency

 
• By David Ridley

Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”

More from HBW Insight

E.l.f. Plans To Acquire Hailey Bieber Beauty Brand For $1Bn

 
• By Eileen Francis

E.l.f. Beauty, Inc. has agreed to acquire celebrity and model Hailey Bieber’s rhode lifestyle beauty brand for $1bn, the firm reported during a 28 May fiscal fourth quarter earnings call, during which it also announced plans to raise product prices to ‘partially’ mitigate the impact of tariffs.

FDA Draft Guidance Waves Green Flag On Changing Color Additives For Drugs In US

 
• By Malcolm Spicer

In a nod to drug manufacturers’ potential interest in moving to natural alternatives for petroleum-based synthetic dyes the agency intends to remove from use, document explains process for asking for approval for “any dye, pigment, or other substance that can impart color to a food, drug, cosmetic,

Urgo Makes Moves In Poland And Belgium

 
• By Tom Gallen

French consumer health player Urgo has added to its dietary supplements offering with separate deals in Poland and Belgium.